ライフサイエンスコーパス: body dysmorphic disorder

1 s from the first relapse prevention study in body dysmorphic disorder.

2 score >/=9 was used as a positive screen for body dysmorphic disorder.

3 rs examined the prevalence and correlates of body dysmorphic disorder, a debilitating and chronic con

4 case notes of 100 consecutive patients with body dysmorphic disorder and compared with the same info

5 fective than desipramine in the treatment of body dysmorphic disorder and is effective even among tho

6 -compulsive disorder (OCD), 20 patients with body dysmorphic disorder, and 10 patients with mood diso

7 hors hypothesized that because patients with body dysmorphic disorder are preoccupied with their appe

8 rs estimated the overall point prevalence of body dysmorphic disorder as 0.7% in women in this age ra

9 dividuals with diagnoses of dysmorphophobia (body dysmorphic disorder) assigned during the same perio

10 ve data have indicated that individuals with body dysmorphic disorder (BDD) have high rates of suicid

11 Body dysmorphic disorder (BDD) is a psychiatric disorder

12 Body dysmorphic disorder (BDD) is a severe psychiatric c

13 Body dysmorphic disorder (BDD) is an obsessive-compulsiv

14 Body Dysmorphic Disorder (BDD) is an underexplored psych

15 Body dysmorphic disorder (BDD) is characterized by preoc

16 Body dysmorphic disorder (BDD) is characterized by preoc

17 Body dysmorphic disorder (BDD) is thought to be associat

18 Research on the pharmacotherapy of body dysmorphic disorder (BDD), a common and often disab

19 This study investigated the course of body dysmorphic disorder (BDD), a relatively common and

20 rown Obsessive Compulsive Scale Modified for Body Dysmorphic Disorder (BDD-YBOCS) (the primary outcom

21 Twenty percent of the patients with body dysmorphic disorder had an occupation or education

22 The prevalence of body dysmorphic disorder in an oculofacial surgical sett

23 Muscle dysmorphia is a form of body dysmorphic disorder in which individuals develop a

24 Body dysmorphic disorder is common, distressing, and oft

25 Their estimate of the point prevalence of body dysmorphic disorder is consistent with data from a

26 Onset of body dysmorphic disorder is usually gradual during adole

27 Body dysmorphic disorder (preoccupation with an imagined

28 Adults (N=100) with DSM-IV body dysmorphic disorder received open-label escitalopra

29 Body dysmorphic disorder severity (in both the intent-to

30 ere were no significant group differences in body dysmorphic disorder severity or insight, depressive

31 Among escitalopram-treated subjects, body dysmorphic disorder severity significantly decrease

32 Body dysmorphic disorder severity significantly improved

33 utcome measures included specific ratings of body dysmorphic disorder severity, delusionality, and fu

34 ior to desipramine in the acute treatment of body dysmorphic disorder symptoms as measured by assessm

35 plausible explanation is that patients with body dysmorphic disorder tend to have an interest in aes

36 Patients screening positively for body dysmorphic disorder tend to have higher postoperati

37 nin reuptake inhibitors may be effective for body dysmorphic disorder, to date no controlled treatmen

38 The authors found that the presence of body dysmorphic disorder was linked to the presence of m

39 The presence of body dysmorphic disorder was significantly associated wi

40 Rates and diagnostic correlates of body dysmorphic disorder were examined by using data fro